Lipocine (LPCN) Assets (2011 - 2025)
Lipocine's Assets came in at $17.01 million for Q4 2025, down 24.5% from $22.51 million a year earlier but up 5.8% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Assets (2011 - 2025) Analysis & Trends
Going back to Q4 2011, Lipocine's Assets data covers 56 quarters.
- Assets has declined in each of the last four years, with a five-year compound annual growth rate of -7.7% (FY2020 to FY2025).
- Going back by year, Assets was $22.51 million in FY2024 (-2.1%), $23 million in FY2023 (-38.7%), $37.54 million in FY2022 (-28.5%) and $52.48 million in FY2021 (+107.0%).
- The five-year range for quarterly Assets is $16.07 million (Q3 2025) to $52.48 million (Q4 2021).
- Year-over-year, Assets has declined for 16 consecutive quarters, with an average decline of 19.2% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q1 2021 (growth of 140.9%), and the weakest in Q4 2023 (a decline of 38.7%).
- Business Quant data shows LPCN's Assets at $16.07 million (Q3 2025), $18.58 million (Q2 2025) and $20.5 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - | 17.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 17.01 Mn |
| Sep 30, 2025 | 16.07 Mn |
| Jun 30, 2025 | 18.58 Mn |
| Mar 31, 2025 | 20.50 Mn |
| Dec 31, 2024 | 22.51 Mn |
| Sep 30, 2024 | 20.70 Mn |
| Jun 30, 2024 | 23.03 Mn |
| Mar 31, 2024 | 25.45 Mn |
| Dec 31, 2023 | 23.00 Mn |
| Sep 30, 2023 | 24.75 Mn |
| Jun 30, 2023 | 30.48 Mn |
| Mar 31, 2023 | 34.02 Mn |
| Dec 31, 2022 | 37.54 Mn |
| Sep 30, 2022 | 39.42 Mn |
| Jun 30, 2022 | 42.19 Mn |
| Mar 31, 2022 | 47.60 Mn |
| Dec 31, 2021 | 52.48 Mn |
| Sep 30, 2021 | 40.39 Mn |
| Jun 30, 2021 | 47.18 Mn |
| Mar 31, 2021 | 50.58 Mn |
API Access
Lipocine Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();